Diabetes mellitus does not alter mortality or hospitalisation risk in patients with newly diagnosed heart failure with preserved ejection fraction: Time to rethink pathophysiological models of disease progression
Introduction Type 2 diabetes is a common and adverse prognostic co-morbidity for patients with heart failure with reduced ejection fraction (HFrEF). The effect of diabetes on long-term outcomes for heart failure with preserved ejection fraction (HFpEF) is less established. Methods Prospective cohort...
Збережено в:
| Автори: | , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
SAGE Publishing
2024-04-01
|
| Серія: | Diabetes & Vascular Disease Research |
| Онлайн доступ: | https://doi.org/10.1177/14791641231224241 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
